News & Updates

Show Multimedia Only

Statin may be more harmful than beneficial in people with dementia

14 Feb 2026

For individuals with dementia, statin use does not appear to provide cardioprotective benefits but rather contributes to an increased risk of hospitalization due to cardiovascular or cerebrovascular events, according to a retrospective study.

Statin may be more harmful than beneficial in people with dementia

14 Feb 2026

Advanced therapy does not affect time to pregnancy in women with IBD

14 Feb 2026 by

Exposure to advanced therapies, including biologics and small molecules, within 3 months of conception is not associated with an increase in time to pregnancy among women with inflammatory bowel disease (IBD), according to the WIsDoM* trial presented at the Crohn’s and Colitis Congress 2026.

Advanced therapy does not affect time to pregnancy in women with IBD

14 Feb 2026

Vitamin D, calcium supplementation does little to improve bone mass in teens

13 Feb 2026 by

For adolescents with perinatally acquired HIV, supplementation with vitamin D3 and calcium appears to have limited benefit in terms of promoting bone accrual and mineralization, as shown in the phase III VITALITY study.

Vitamin D, calcium supplementation does little to improve bone mass in teens

13 Feb 2026

Hypertensive disorders of pregnancy linked to LV remodelling

13 Feb 2026

An association exists between hypertensive disorders of pregnancy (HDP) and adverse left ventricular (LV) remodelling, which is partially mediated by post-pregnancy BMI, suggests a study.

Hypertensive disorders of pregnancy linked to LV remodelling

13 Feb 2026

Mirikizumab improves IBD outcomes during induction, maintenance periods

13 Feb 2026 by

Treatment with mirikizumab results in significant improvements in clinical, endoscopic, and histologic outcomes during induction and maintenance phases in patients with Crohn’s disease (CD) or ulcerative colitis (UC), according to an updated meta-analysis of randomized controlled trials (RCTs).

Mirikizumab improves IBD outcomes during induction, maintenance periods

13 Feb 2026

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

13 Feb 2026 by

Treatment with either vedolizumab or ustekinumab delivers significant and meaningful benefits to patients with Crohn’s disease (CD), but each has its distinct therapeutic profile with complementary advantages, reports a real-world study presented at CCC 2026.

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

13 Feb 2026

Drinking water salinity may affect BP levels

13 Feb 2026 by

A systematic review and meta-analysis show an association between elevated salinity in drinking water and higher systolic blood pressure (SBP) and diastolic BP (DBP) levels, particularly among individuals residing in coastal areas.

Drinking water salinity may affect BP levels

13 Feb 2026

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

13 Feb 2026 by

A 67-year-old man was diagnosed with polycythaemia vera (PV) in 2005. Over the next several years, he received various cytoreductive agents, including anagrelide, pegylated interferon (IFN) and hydroxyurea.

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

13 Feb 2026

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

13 Feb 2026

Peppermint oil or peppermint sweets appear to do little in terms of relieving pain in children with irritable bowel syndrome (IBS) or functional abdominal pain–not otherwise specified, as shown in a study.

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

13 Feb 2026

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

13 Feb 2026 by

The use of intra-arterial (IA) alteplase following a successful endovascular thrombectomy (EVT) improves 90-day functional outcome in patients with large-vessel occlusion (LVO) acute ischaemic stroke compared with EVT-alone, according to the CHOICE 2* trial presented at ISC 2026.

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

13 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Statin may be more harmful than beneficial in people with dementia

Statin may be more harmful than beneficial in people with dementia

Advanced therapy does not affect time to pregnancy in women with IBD

Advanced therapy does not affect time to pregnancy in women with IBD

Vitamin D, calcium supplementation does little to improve bone mass in teens

Vitamin D, calcium supplementation does little to improve bone mass in teens

Hypertensive disorders of pregnancy linked to LV remodelling

Hypertensive disorders of pregnancy linked to LV remodelling

Mirikizumab improves IBD outcomes during induction, maintenance periods

Mirikizumab improves IBD outcomes during induction, maintenance periods

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

Vedolizumab vs ustekinumab: Which holds greater advantage for patients with CD?

Drinking water salinity may affect BP levels

Drinking water salinity may affect BP levels

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

JAK1/2 inhibitor provides rapid and durable disease control in a patient with myelofibrosis

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

Peppermint oil, sweets of little benefit in paediatric IBS and functional abdominal pain

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults

Intra-arterial alteplase after successful EVT yields excellent functional outcome in adults